These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34365891)

  • 41. Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.
    He R; Zheng M; Lian L; Yao X
    Cells; 2021 May; 10(5):. PubMed ID: 34067647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Motor unit number index (MUNIX) versus motor unit number estimation (MUNE): a direct comparison in a longitudinal study of ALS patients.
    Boekestein WA; Schelhaas HJ; van Putten MJ; Stegeman DF; Zwarts MJ; van Dijk JP
    Clin Neurophysiol; 2012 Aug; 123(8):1644-9. PubMed ID: 22321299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.
    Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR
    J Alzheimers Dis; 2017; 58(1):163-170. PubMed ID: 28387671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study.
    Menon P; Geevasinga N; Yiannikas C; Howells J; Kiernan MC; Vucic S
    Lancet Neurol; 2015 May; 14(5):478-84. PubMed ID: 25843898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring disease progression in primary lateral sclerosis.
    Gilmore M; Elman L; Babu S; Andres P; Floeter MK
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(sup1):59-66. PubMed ID: 33602016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Split-hand plus sign in ALS: differential involvement of the flexor pollicis longus and intrinsic hand muscles.
    Menon P; Bae JS; Mioshi E; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):315-8. PubMed ID: 23121291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
    Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis--A Pilot Study.
    Maier A; Deigendesch N; Müller K; Weishaupt JH; Krannich A; Röhle R; Meissner F; Molawi K; Münch C; Holm T; Meyer R; Meyer T; Zychlinsky A
    PLoS One; 2015; 10(10):e0139684. PubMed ID: 26444282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis.
    Meucci N; Nobile-Orazio E; Scarlato G
    J Neurol; 1996 Feb; 243(2):117-20. PubMed ID: 8750546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis.
    Quinn C; Edmundson C; Dahodwala N; Elman L
    Muscle Nerve; 2020 Apr; 61(4):508-511. PubMed ID: 31743477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged distal latency of the median motor nerve is associated with poor prognosis in amyotrophic lateral sclerosis.
    Sato M; Nakamura T; Nagashima K; Fujita Y; Ikeda Y
    Neurol Res; 2021 Mar; 43(3):191-198. PubMed ID: 33054692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.
    Williams JR; Fitzhenry D; Grant L; Martyn D; Kerr DA
    BMC Neurol; 2013 Nov; 13():160. PubMed ID: 24499173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The review of questionnaires and scales evaluating patients with amyotrophic lateral sclerosis].
    Bužgová R; Kozáková R; Zeleníková R; Sikorová L
    Cas Lek Cesk; 2018; 157(1):41-45. PubMed ID: 29564907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oropharyngeal dysphagia in amyotrophic lateral sclerosis: neurological and dysphagia specific rating scales.
    Kidney D; Alexander M; Corr B; O'toole O; Hardiman O
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):150-3. PubMed ID: 15512903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health Status Perspectives in Amyotrophic Lateral Sclerosis.
    Pinto S; de Carvalho M
    Neurodegener Dis; 2017; 17(6):323-329. PubMed ID: 29084402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
    Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
    de la Rubia JE; Drehmer E; Platero JL; Benlloch M; Caplliure-Llopis J; Villaron-Casales C; de Bernardo N; AlarcÓn J; Fuente C; Carrera S; Sancho D; GarcÍa-Pardo P; Pascual R; JuÁrez M; Cuerda-Ballester M; Forner A; Sancho-Castillo S; Barrios C; Obrador E; Marchio P; Salvador R; Holmes HE; Dellinger RW; Guarente L; Estrela JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):115-122. PubMed ID: 30668199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Determinants of Disease Progression in Amyotrophic Lateral Sclerosis-A Retrospective Cohort Study.
    Requardt MV; Görlich D; Grehl T; Boentert M
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33921250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of hyperexcitability of spinal motoneurons in patients with amyotrophic lateral sclerosis.
    Marchand-Pauvert V; Peyre I; Lackmy-Vallee A; Querin G; Bede P; Lacomblez L; Debs R; Pradat PF
    J Physiol; 2019 Nov; 597(22):5445-5467. PubMed ID: 31523813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.